Guest Post by William G. Nelson, MD, PhD
Editor-in-Chief, Cancer Today
Nearly 1.7 million new cancer cases and roughly 600,000 cancer deaths are expected in the United States in 2017. The good news …
Differences and Disparities in Cancer
Cancer Today
Understanding Premalignancy and Cancer Risk
Prevention is often said to be more powerful than a cure. With an eye toward thwarting the disease, some researchers are trying to understand the molecular processes that are present in cells before cancer develops. These efforts, which analyze the potential power of premalignancy, are featured in the spring issue of Cancer Today.
Read MoreAACR Expanding Its Community Outreach
As spring is a time for flowers to bloom, public education at the American Association for Cancer Research (AACR) has also blossomed these past few months.
During the AACR Annual Meeting …
Seeking a Second Opinion
After being diagnosed with cancer, some patients consider getting a second opinion. This may involve a pathologist confirming a medical report or an oncologist weighing in on a treatment plan. Patients can seek second opinions when they are first diagnosed with cancer, or well into cancer treatment.
Read MorePalliative Care: Putting a Cloak on Cancer
Hospice care and palliative care share similar goals in providing relief of pain and other symptoms, but they remain distinct: For cancer patients, hospice care can aid the terminally ill who have no treatment options, but palliative care can potentially improve quality of life for anyone with the disease, beginning at diagnosis.
Read MoreNew Guidelines Suggest Individualized Approach to Prostate Cancer Screening
The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55 to 69 of the potential benefits and harms of prostate-specific antigen (PSA) blood testing to screen for prostate cancer. The draft says the decision to be screened is an individual one that should be made after consulting with a physician.
Read MoreAACR Annual Meeting 2017: The Patient Perspective
The American Association for Cancer Research (AACR) Annual Meeting 2017 brought some of the world’s greatest scientific minds to Washington, D.C., to address research challenges in cancer. But significant findings also came from cancer patient advocates and survivors who attended the meeting.
Read MorePaving the Way for Research on Combination Therapies
Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession.
Read MoreResearching Cancer in the LGBT Community
Lesbian, gay, bisexual, and transgender (LGBT) people may be at increased risk of certain cancers.
Read MoreCancer Today Nears Fifth Anniversary
Cancer Today empowers readers to be active and involved in their treatment and survivor experiences.
Read More